The evolving role of early-phase clinical trials reflects a broader truth: decisions made early carry increasing weight in ...

Phase 3 manufacturing campaign on track for completion no later than third quarter 2026, supporting expected pivotal trial in ...

Official FDA meeting minutes and Phase 2 data provide guidance on the pivotal Phase 3 registration path for CAD-1005 in heparin-induced thrombocytopenia (HIT) ...

Advancing small molecules from R&D to GMP requires coordinated strategies to support phase I clinical manufacturing.

MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today ...

A Zionsville-based developer is preparing for the next phase of development at a 48-acre residential and commercial project along Michigan Road in Zionsville. Pittman Partners plans to build up to 225 ...